Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

被引：14
|
作者：
Castilla, J. [1 ,2 ]
Martinez-Baz, I. [1 ,2 ]
Navascues, A. [3 ]
Fernandez-Alonso, M. [4 ]
Reina, G. [4 ]
Guevara, M. [1 ,2 ]
Chamorro, J. [3 ]
Ortega, M. T. [5 ]
Albeniz, E. [6 ]
Pozo, F. [7 ]
Ezpeleta, C. [3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Valencia, Spain
[3] Complejo Hosp Navarra, Pamplona, Spain
[4] Univ Navarra Clin, Pamplona, Spain
[5] Hosp Reina Sofia, Tudela, Spain
[6] Direcc Atenc Primaria, Navarre Hlth Serv, Pamplona, Spain
[7] WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Inst Salud Carlos III, Majadahonda, Spain
来源：
EUROSURVEILLANCE | 2014年 / 19卷 / 06期
关键词：
D O I：
10.2807/1560-7917.ES2014.19.6.20700
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [31] Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19
    Stuurman, Anke L.
    Bollaerts, Kaatje
    Alexandridou, Maria
    Biccler, Jorne
    Domingo, Javier Diez
    Nohynek, Hanna
    Rizzo, Caterina
    Turunen, Topi
    Riera-Montes, Margarita
    VACCINE, 2020, 38 (41) : 6455 - 6463
  • [32] Population-Based Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection in Southern China, 2023-2024 Season
    Gao, Xin
    Sun, Yexiang
    Shen, Peng
    Guo, Jinxin
    Chen, Yunpeng
    Yin, Yueqi
    Liu, Zhike
    Zhan, Siyan
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (09):
  • [33] Vaccine effectiveness against laboratory-confirmed influenza in infants A matched case control study
    Cochran, Lauren W.
    Black, Steven
    Klein, Nicola P.
    Dekker, Cornelia L.
    Lewis, Edwin
    Reingold, Arthur L.
    HUMAN VACCINES, 2010, 6 (09): : 729 - 735
  • [34] Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada
    Buchan, Sarah A.
    Chung, Hannah
    Campitelli, Michael A.
    Crowcroft, Natasha S.
    Gubbay, Jonathan B.
    Karnauchow, Timothy
    Katz, Kevin
    McGeer, Allison J.
    McNally, J. Dayre
    Richardson, David
    Richardson, Susan E.
    Rosella, Laura C.
    Simor, Andrew
    Smieja, Marek
    Tran, Dat
    Zahariadis, George
    Kwong, Jeffrey C.
    PLOS ONE, 2017, 12 (11):
  • [35] Early vaccine effectiveness estimates against medically attended laboratory-confirmed influenza based on influenza surveillance, Beijing, China, 2024/25 season
    Sun, Ying
    Shi, Weixian
    Zhang, Daitao
    Ma, Chunna
    Feng, Zhaomin
    Zhang, Jiaojiao
    Wu, Dan
    Zhang, Li
    Li, Jia
    Duan, Wei
    Wang, Yingying
    Ma, Jiaxin
    Zhang, Lu
    Hu, Xiaodi
    Yang, Peng
    Wang, Quanyi
    EUROSURVEILLANCE, 2025, 30 (07)
  • [36] Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019
    Mouratidou, Elisavet
    Lambrou, Angeliki
    Andreopoulou, Anastasia
    Gioula, Georgia
    Exindari, Maria
    Kossyvakis, Athanasios
    Pogka, Vasiliki
    Mentis, Andreas
    Georgakopoulou, Theano
    Lytras, Theodore
    VACCINE, 2020, 38 (12) : 2715 - 2724
  • [37] Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12
    Castilla, J.
    Martinez-Baz, I.
    Martinez-Artola, V.
    Reina, G.
    Pozo, F.
    Garcia Cenoz, M.
    Guevara, M.
    Moran, J.
    Irisarri, F.
    Arriazu, M.
    Albeniz, E.
    Ezpeleta, C.
    Barricarte, A.
    EUROSURVEILLANCE, 2013, 18 (05): : 17 - 24
  • [38] Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024
    Zhu, Sophie
    Quint, Joshua
    Leon, Tomas M.
    Sun, Monica
    Li, Nancy J.
    Tenforde, Mark W.
    Jain, Seema
    Schechter, Robert
    Hoover, Cora
    Murray, Erin L.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2024, 73 (08): : 175 - 179
  • [39] Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: A test-negative study
    Lytras, Theodore
    Kossyvakis, Athanasios
    Melidou, Angeliki
    Exindari, Maria
    Gioula, Georgia
    Pogka, Vasiliki
    Malisiovas, Nikolaos
    Mentis, Andreas
    VACCINE, 2015, 33 (02) : 367 - 373
  • [40] Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection
    Pebody, R. G.
    Andrews, N.
    McMenamin, J.
    Durnall, H.
    Ellis, J.
    Thompson, C. I.
    Robertson, C.
    Cottrell, S.
    Smyth, B.
    Zambon, M.
    Moore, C.
    Fleming, D. M.
    Watson, J. M.
    EUROSURVEILLANCE, 2013, 18 (05): : 25 - 32
12345